These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38410247)

  • 1. Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center's experience.
    Živković SA; Lacomis D; Soman P
    Front Cardiovasc Med; 2024; 11():1345608. PubMed ID: 38410247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.
    Kleefeld F; Scherret E; Knebel F; Messroghli D; Heidecker B; Wetz C; Schatka I; Barzen G; Tschöpe C; Amthauer H; Hahn K
    Amyloid; 2022 Jun; 29(2):92-101. PubMed ID: 34994254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
    Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
    JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
    Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
    Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
    Nativi-Nicolau J; Siu A; Dispenzieri A; Maurer MS; Rapezzi C; Kristen AV; Garcia-Pavia P; LoRusso S; Waddington-Cruz M; Lairez O; Witteles R; Chapman D; Amass L; Grogan M;
    JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
    Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
    J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.
    Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M
    Eur J Prev Cardiol; 2024 Aug; 31(11):1410-1417. PubMed ID: 38456769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal manifestations associated with transthyretin-mediated (ATTR) amyloidosis: a systematic review.
    Aldinc E; Campbell C; Gustafsson F; Beveridge A; Macey R; Marr L; Summers C; Zhang D
    BMC Musculoskelet Disord; 2023 Sep; 24(1):751. PubMed ID: 37740174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.
    Nakagawa M; Sekijima Y; Yazaki M; Tojo K; Yoshinaga T; Doden T; Koyama J; Yanagisawa S; Ikeda S
    Amyloid; 2016; 23(1):58-63. PubMed ID: 26852880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transthyretin amyloidosis: Putting myopathy on the map.
    Pinto MV; Milone M; Mauermann ML; Dyck PJB; Alhammad R; McPhail ED; Grogan M; Liewluck T
    Muscle Nerve; 2020 Jan; 61(1):95-100. PubMed ID: 31587306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological manifestations of ATTR amyloidosis].
    Pernice HF; Hahn K
    Inn Med (Heidelb); 2023 Sep; 64(9):848-854. PubMed ID: 37555967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
    Bézard M; Kharoubi M; Galat A; Poullot E; Guendouz S; Fanen P; Funalot B; Moktefi A; Lefaucheur JP; Abulizi M; Deux JF; Gendre T; Audard V; El Karoui K; Canoui-Poitrine F; Zaroui A; Itti E; Teiger E; Planté-Bordeneuve V; Oghina S; Damy T
    Eur J Heart Fail; 2021 Feb; 23(2):264-274. PubMed ID: 33094885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP).
    Fernandes F; Luzuriaga GDCJ; da Fonseca GWP; Correia EB; Carvalho AAS; Macedo AVS; Coelho-Filho OR; Scheinberg P; Antunes MO; Schwartzmann PV; Mangini S; Marques W; Simões MV
    Orphanet J Rare Dis; 2024 Jul; 19(1):273. PubMed ID: 39033298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey.
    González-Moreno J; Losada-López I; Cisneros-Barroso E; Garcia-Pavia P; González-Costello J; Muñoz-Beamud F; Campistol JM; Fernandez-Torron R; Chapman D; Amass L
    Neurol Ther; 2021 Dec; 10(2):833-845. PubMed ID: 34331265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Approaches for Transthyretin Amyloidosis.
    Koike H; Okumura T; Murohara T; Katsuno M
    Cardiol Ther; 2021 Dec; 10(2):289-311. PubMed ID: 34089151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.
    Koike H; Katsuno M
    Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30764529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
    Nativi-Nicolau J; Judge DP; Hoffman JE; Gundapaneni B; Keohane D; Sultan MB; Grogan M
    ESC Heart Fail; 2021 Oct; 8(5):3875-3884. PubMed ID: 34432383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).
    Ladefoged B; Clemmensen T; Dybro A; Hartig-Andreasen C; Kirkeby L; Gormsen LC; Bomholt P; Gillmore J; Poulsen SH
    ESC Heart Fail; 2023 Feb; 10(1):234-244. PubMed ID: 36193570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial occurrences of cardiac wild-type transthyretin amyloidosis: a case series.
    Westin OM; Clemmensen TS; Hansen AT; Gustafsson F; Poulsen SH
    Eur Heart J Case Rep; 2024 May; 8(5):ytae199. PubMed ID: 38765770
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.